Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators.

JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.

PMID:
26618534
2.

Assessing Adolescent Substance Abuse Programs with Updated Quality Indicators: The Development of a Consumer Guide for Adolescent Treatment.

Cacciola JS, Meyers K, Bates SE, Rosenwasser B, Arria A, McLellan AT.

J Child Adolesc Subst Abuse. 2015;24(3):142-154. Epub 2015 Mar 6.

3.

National Trends in Adolescent Substance Use Disorders and Treatment Availability: 2003-2010.

Mericle AA, Arria AM, Meyers K, Cacciola J, Winters KC, Kirby K.

J Child Adolesc Subst Abuse. 2015;24(5):255-263.

4.

Effect of patient choice in an adaptive sequential randomization trial of treatment for alcohol and cocaine dependence.

McKay JR, Drapkin ML, Van Horn DH, Lynch KG, Oslin DW, DePhilippis D, Ivey M, Cacciola JS.

J Consult Clin Psychol. 2015 Dec;83(6):1021-32. doi: 10.1037/a0039534. Epub 2015 Jul 27.

PMID:
26214544
5.

A critical component of the continuum of care for substance use disorders: recovery homes in Philadelphia.

Mericle AA, Miles J, Cacciola J.

J Psychoactive Drugs. 2015 Jan-Mar;47(1):80-90. doi: 10.1080/02791072.2014.976726.

PMID:
25715076
6.

Using Web searches to track interest in synthetic cannabinoids (a/k/a 'herbal incense').

Curtis B, Alanis-Hirsch K, Kaynak Ö, Cacciola J, Meyers K, McLellan AT.

Drug Alcohol Rev. 2015 Jan;34(1):105-8. doi: 10.1111/dar.12189. Epub 2014 Sep 6.

7.

Providing alcohol for underage youth: what messages should we be sending parents?

Kaynak Ö, Winters KC, Cacciola J, Kirby KC, Arria AM.

J Stud Alcohol Drugs. 2014 Jul;75(4):590-605. Review.

8.

Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.

Brown DG, Bernstein PR, Griffin A, Wesolowski S, Labrecque D, Tremblay MC, Sylvester M, Mauger R, Edwards PD, Throner SR, Folmer JJ, Cacciola J, Scott C, Lazor LA, Pourashraf M, Santhakumar V, Potts WM, Sydserff S, Giguère P, Lévesque C, Dasser M, Groblewski T.

J Med Chem. 2014 Feb 13;57(3):733-58. doi: 10.1021/jm4014828. Epub 2014 Jan 27.

PMID:
24410637
9.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

10.

Addiction Severity Index (ASI) summary scores: comparison of the Recent Status Scores of the ASI-6 and the Composite Scores of the ASI-5.

Denis CM, Cacciola JS, Alterman AI.

J Subst Abuse Treat. 2013 Nov-Dec;45(5):444-50. doi: 10.1016/j.jsat.2013.06.003. Epub 2013 Jul 23.

11.

Development and initial evaluation of the Brief Addiction Monitor (BAM).

Cacciola JS, Alterman AI, Dephilippis D, Drapkin ML, Valadez C Jr, Fala NC, Oslin D, McKay JR.

J Subst Abuse Treat. 2013 Mar;44(3):256-63. doi: 10.1016/j.jsat.2012.07.013. Epub 2012 Aug 14.

12.

Comparison of two ASI-based standardized patient placement approaches.

Camilleri AC, Cacciola JS, Jenson MR.

J Addict Dis. 2012;31(2):118-29. doi: 10.1080/10550887.2012.665727.

PMID:
22540434
13.

Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil.

Kessler F, Cacciola J, Alterman A, Faller S, Souza-Formigoni ML, Cruz MS, Brasiliano S, Pechansky F.

Rev Bras Psiquiatr. 2012 Mar;34(1):24-33.

14.

The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-up.

Ruetsch C, Tkacz J, McPherson TL, Cacciola J.

Addict Behav. 2012 May;37(5):686-9. doi: 10.1016/j.addbeh.2012.01.013. Epub 2012 Jan 25.

PMID:
22348921
15.

Compliance with buprenorphine medication-assisted treatment and relapse to opioid use.

Tkacz J, Severt J, Cacciola J, Ruetsch C.

Am J Addict. 2012 Jan-Feb;21(1):55-62. doi: 10.1111/j.1521-0391.2011.00186.x. Epub 2011 Nov 18.

PMID:
22211347
16.

Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators.

N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. Erratum in: N Engl J Med. 2012 Jul 5;367(1):93.

17.

Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.

Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):357-68. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.001.

18.

Recent status scores for version 6 of the Addiction Severity Index (ASI-6).

Cacciola JS, Alterman AI, Habing B, McLellan AT.

Addiction. 2011 Sep;106(9):1588-602. doi: 10.1111/j.1360-0443.2011.03482.x.

19.

Relationship of Mental Health and Illness in Substance Abuse Patients.

Alterman AI, Cacciola JS, Ivey MA, Coviello DM, Lynch KG, Dugosh KL, Habing B.

Pers Individ Dif. 2010 Dec 1;49(8):880-884.

20.

A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: study feasibility and sample description.

Ruetsch C, Cacciola J, Tkacz J.

J Subst Abuse Treat. 2010 Dec;39(4):307-17. doi: 10.1016/j.jsat.2010.07.003. Epub 2010 Aug 21.

PMID:
20728299

Supplemental Content

Loading ...
Support Center